tm
Seeing Is Believing
tm
Seeing Is Believing
KNTE is currently covered by 6 analysts with an average price target of $7.11. This is a potential upside of $4.46 (168.3%) from yesterday's end of day stock price of $2.65.
Kinnate Biopharma 's activity chart (see below) currently has 10 price targets and 30 ratings on display. The stock rating distribution of KNTE is 61.9% BUY and 38.1% HOLD.
Analysts average stock forecasts to be materialized ratio is 8.84% with an average time for these price targets to be met of 16.86 days.
Highest price target for KNTE is $4, Lowest price target is $2, average price target is $7.11.
Most recent stock forecast was given by BENJAMIN BURNETT from STIFEL on 26-Feb-2024.
Currently out of the existing stock ratings of KNTE, 13 are a BUY (61.9%), 8 are a HOLD (38.1%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
2.59
5.4
1 months 20 days ago
1/7 (14.29%)
$0.14 (5.71%)
4
Hold
2
$-0.65 (-24.53%)
2
2 months 29 days ago
1/7 (14.29%)
$-0.36 (-15.25%)
57
Hold
4
$1.35 (50.94%)
6 months 27 days ago
0/5 (0%)
$2.5 (166.67%)
Buy
2
$-0.65 (-24.53%)
6 months 27 days ago
1/3 (33.33%)
$0.5 (33.33%)
57
Hold
6 months 27 days ago
0/1 (0%)
$21.33 (182.78%)
What is KNTE (Kinnate Biopharma ) average time for price targets to be met?
Which analyst has the current highest performing score on KNTE (Kinnate Biopharma ) with a proven track record?
Which analyst has the current lower performing score on KNTE (Kinnate Biopharma ) with a proven track record?
Which analyst has the most public recommendations on KNTE (Kinnate Biopharma )?
Which analyst is the currently most bullish on KNTE (Kinnate Biopharma )?
Which analyst is the currently most reserved on KNTE (Kinnate Biopharma )?
